Medtronic PLC (MDT)
79.26
+0.18
(+0.23%)
USD |
NYSE |
Apr 18, 16:00
79.50
+0.24
(+0.30%)
After-Hours: 20:00
Medtronic SG&A Expense (Quarterly): 2.673B for Jan. 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 2.673B |
October 31, 2023 | 2.686B |
July 31, 2023 | 2.613B |
April 30, 2023 | 2.616B |
January 31, 2023 | 2.615B |
October 31, 2022 | 2.617B |
July 31, 2022 | 2.567B |
April 30, 2022 | 2.569B |
January 31, 2022 | 2.561B |
October 31, 2021 | 2.615B |
July 31, 2021 | 2.547B |
April 30, 2021 | 2.595B |
January 31, 2021 | 2.537B |
October 31, 2020 | 2.60B |
July 31, 2020 | 2.417B |
April 30, 2020 | 2.359B |
January 31, 2020 | 2.587B |
October 31, 2019 | 2.62B |
July 31, 2019 | 2.543B |
April 30, 2019 | 2.62B |
January 31, 2019 | 2.596B |
October 31, 2018 | 2.605B |
July 31, 2018 | 2.597B |
April 30, 2018 | 2.596B |
January 31, 2018 | 2.523B |
Date | Value |
---|---|
October 31, 2017 | 2.539B |
July 31, 2017 | 2.58B |
April 30, 2017 | 2.786B |
January 31, 2017 | 2.388B |
October 31, 2016 | 2.416B |
July 31, 2016 | 2.428B |
April 30, 2016 | 2.36B |
January 31, 2016 | 2.317B |
October 31, 2015 | 2.343B |
July 31, 2015 | 2.449B |
April 30, 2015 | 2.404B |
January 31, 2015 | 1.487B |
October 31, 2014 | 1.507B |
July 31, 2014 | 1.506B |
April 30, 2014 | 1.539B |
January 31, 2014 | 1.454B |
October 31, 2013 | 1.438B |
July 31, 2013 | 1.416B |
April 30, 2013 | 1.475B |
January 31, 2013 | 1.401B |
October 31, 2012 | 1.417B |
July 31, 2012 | 1.405B |
April 30, 2012 | 1.462B |
January 31, 2012 | 1.371B |
October 31, 2011 | 1.41B |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
2.359B
Minimum
Apr 2020
2.686B
Maximum
Oct 2023
2.578B
Average
2.598B
Median
SG&A Expense (Quarterly) Benchmarks
Abbott Laboratories | 2.724B |
Boston Scientific Corp | 1.379B |
Stryker Corp | 1.941B |
Axonics Inc | 66.19M |
Conmed Corp | 117.96M |